Twist Bioscience (TWST) Other Operating Expenses (2017 - 2026)

Twist Bioscience (TWST) has reported Other Operating Expenses for 10 consecutive years, with $53.6 million the latest figure, recorded in Q1 2026.

• On a quarterly basis, Other Operating Expenses rose 14.6% year-over-year to $53.6 million in Q1 2026; TTM through Jun 2026 was $103.3 million, a 26.98% decrease from a year earlier, with the FY2025 full-year figure at $48.8 million, changed N/A from the prior year.
• Other Operating Expenses was $53.6 million for Q1 2026 at Twist Bioscience, up from $49.7 million in the prior quarter.
• Over five years, Other Operating Expenses peaked at $53.6 million in Q1 2026 and troughed at $581000.0 in Q2 2023.
• A 5-year average of $23.8 million and a median of $6.0 million in 2022 frame the typical range for Other Operating Expenses.
• Across the five-year window, Other Operating Expenses soared 324.22% in 2022 and plunged 86.27% in 2023, its largest moves.
• Over 5 years, Other Operating Expenses stood at $4.1 million in 2022, then slumped by 85.95% to $581000.0 in 2023, then soared by 7795.52% to $45.9 million in 2024, then increased by 8.4% to $49.7 million in 2025, then grew by 7.78% to $53.6 million in 2026.
• The last three Other Operating Expenses figures came in at $53.6 million (Q1 2026), $49.7 million (Q4 2025), and $48.8 million (Q2 2025), per Business Quant data.